Skip to main content

Table 3 Results of univariate analysis of overall survival in patients with mCRC

From: Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study

Variables

Hazard ratio

95%CI

P-value

Age (years) (≥ 65 versus < 65)

0.918

0.56–1.261

0.400

Gender

1.432

1.037–1.977

0.029

MPV (≥ 9.75 fL versus < 9.75 fL)

1.398

1.005–1.946

0.047

WBC

1.082

1.018–1.150

0.011

ANC

1.084

1.016–1.157

0.015

Lymphocyte

0.861

0.64–1.157

0.320

Hemoglobin (≤120 × 109/L vs.>120 × 109/L)

0.630

0.453–0.87

0.006

PLT

1.002

1–1.003

0.018

PCT

4.234

1.17–15.322

0.028

PDW

0.961

0.901–1.026

0.234

PLR

1.003

1–1.004

0.002

NLR

1.066

1.007–1.128

0.028

Efficacy

1.529

1.285–1.820

0.000

  1. Abbreviation: see Table 1 and Table 2